[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351543-105":59,"doc-detail-351543-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-molecular-landscape-of-castle-a-rare-thymus-like-head-and-neck-cancer","The Molecular Landscape of CASTLE: A Rare Thymus-like Head and Neck Cancer","","Carcinoma showing thymus-like differentiation (CASTLE) is a rare malignancy in the thyroid or neck with an uncertain cellular origin, making diagnosis and treatment difficult. Integrated whole-exome and transcriptome sequencing were performed on six CASTLE and six thymic carcinoma samples. Analyses included somatic mutations, mutational signatures, differential gene expression, and tumor microenvironment characterization versus other thyroid cancers. CASTLE showed higher tumor mutational burden, lacked common BRAF/RAS thyroid mutations, and exhibited gene alterations and signatures linked to mismatch repair deficiency and oxidative damage. Immune-rich “immune-hot” microenvironments and thyroid marker downregulation were observed, supporting athymic origin, with immunogenic features suggesting potential benefit from PD-1/PD-L1 checkpoint inhibition and precision oncology targets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-molecular-landscape-of-castle-a-rare-thymus-like-head-and-neck-cancer/351543/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-molecular-landscape-of-castle-a-rare-thymus-like-head-and-neck-cancer/351543.png","ImageObject",300,407,{"name":92,"@type":93},"นรินทร์","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is CASTLE and why is it challenging to manage clinically?","Question",{"text":112,"@type":113},"CASTLE is a rare thyroid/neck malignancy showing thymus-like differentiation with an uncertain cellular origin. Its rarity and overlapping histology with other tumors make both diagnosis and treatment difficult.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the molecular landscape of CASTLE investigated in this study?",{"text":117,"@type":113},"The study used integrated whole-exome sequencing and transcriptome sequencing on CASTLE and thymic carcinoma samples. It included mutation profiling, mutational signature deconvolution, differential gene expression, and tumor microenvironment characterization.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular and immune features distinguish CASTLE from thymic carcinoma?",{"text":121,"@type":113},"CASTLE demonstrated higher median tumor mutational burden than thymic carcinoma and lacked common BRAF/RAS thyroid mutations. Transcriptomic findings in one CASTLE case showed downregulation of thyroid follicular markers and an immune-rich “immune-hot” microenvironment resembling thymic carcinoma.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351543,1790183358,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","Article  \nThe Molecular Landscape of CASTLE: A Rare Thymus-like Head and Neck Cancer  \nWilliam C. Cho 1, *,†, Allen C. S. Yu 2,†, Wah Cheuk 3, Aldrin K. Y. Yim 2, James C. H. Chow 1, John K. C. Chan 3 and Ka M. Cheung 1, *  \nAcademic Editor: AlpoVuorio  \nReceived: 5 February 2026  \nRevised: 23 March 2026  \nAccepted: 1 April 2026  \nPublished: 14 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China  \n2 Codex Genetics Ltd., Hong Kong, China  \n3 Department of Pathology, Queen Elizabeth Hospital, Hong Kong, China  \n* Correspondence: williamcscho@gmail.com or [chocs@ha.orga.hk](chocs@ha.orga.hk) (W.C.C.); [ckm792@ha.org.hk](ckm792@ha.org.hk) (K.M.C.)† These authors contributed equally to this work.  \nAbstract  \nCarcinoma showing thymus-like differentiation (CASTLE) is a rare malignancy arising in the thyroid or neck, with an uncertain cellular origin that complicates both diagnosis and treatment. To better understand its molecular underpinnings and identify potential therapeutic avenues, we conducted integrated whole-exome and transcriptome sequencing on six CASTLE and six thymic carcinoma samples. Whole-exome sequencing (WES) was performed on all 12 samples, while RNA sequencing was successful for 1 CASTLE and 6 thymic carcinoma samples. Our analysis included somatic mutation profiling, mutational signature deconvolution, differential gene expression, and characterization of tumor microenvironment for the cases with available data, with comparisons to genomic data from other thyroid cancers. CASTLE tumors demonstrated a higher median tumor mutational burden than thymic carcinoma and lacked the common BRAF and RAS mutations typically found in thyroid cancers. They harbored alterations in genes such as TRHDE, cilia-associated genes (ANKS6, CFAP46, DNAH6), and Wnt signaling components (TRRAP, BCL9L), as well as mutational signatures suggestive of mismatch repair deficiency and oxidative damage. MSIsensor-pro analysis of the WES data provided support for the potential for mismatch repair deficiency in a subset of CASTLE samples. Exploratory transcriptomic analysis from a single CASTLE case showed downregulation of thyroid follicular markers and an “immune-hot”, lymphocyte-rich microenvironment, closely resembling that of thymic carcinoma. While these findings require validation in larger cohorts, they support athymic origin for CASTLE and establish its molecular distinction from follicular-derived thyroid cancers. The immunogenic tumor landscape suggests that immune checkpoint inhibitors, particularly those targeting PD-1/PD-L1, may be a promising therapeutic strategy, alongside emerging targets for precision oncology.  \nKeywords: carcinoma showing thymus-like differentiation (CASTLE); thymic carcinoma; next-generation sequencing (NGS); tumor mutational burden (TMB); tumor microenvironment (TME); immunotherapy  \n1. Introduction  \nCarcinoma showing thymus-like differentiation (CASTLE) is a rare and poorly understood neoplasm arising in the soft tissues of the neck or within the thyroid gland. First [reported by Miyauchi et al. in 1985](reported by Miyauchi et al. in 1985) [1] as “thymus carcinoma in the thyroid”, it was later  \nformally termed “CASTLE”by Chan and Rosai in 1991 [2] . Recognized by the World Health Organization (WHO) in 2004 as a distinct clinicopathological entity of thyroid tumors [3], CASTLE accounts for only about 0.1–0.15% of all thyroid cancers [4] . It is thought to originate from ectopic thymic tissue or branchial pouch remnants within the thyroid gland [5] . Patients typically present with a painless, slowly growing neck mass, though hoarseness or dysphagia may occur due to local invasion into the recurrent laryngeal nerve or esophagus. Clinical and imaging findings often r","cbCaivfYUzwa6L9y","https://ap.wps.com/l/cbCaivfYUzwa6L9y","pdf",4842826,16,"English","# Abstract\n# 1. Introduction\n# 2. Results\n## 2.1. Cohort Characteristics","[{\"question\":\"What is CASTLE and why is it challenging to manage clinically?\",\"answer\":\"CASTLE is a rare thyroid/neck malignancy showing thymus-like differentiation with an uncertain cellular origin. Its rarity and overlapping histology with other tumors make both diagnosis and treatment difficult.\"},{\"question\":\"How was the molecular landscape of CASTLE investigated in this study?\",\"answer\":\"The study used integrated whole-exome sequencing and transcriptome sequencing on CASTLE and thymic carcinoma samples. It included mutation profiling, mutational signature deconvolution, differential gene expression, and tumor microenvironment characterization.\"},{\"question\":\"What molecular and immune features distinguish CASTLE from thymic carcinoma?\",\"answer\":\"CASTLE demonstrated higher median tumor mutational burden than thymic carcinoma and lacked common BRAF/RAS thyroid mutations. Transcriptomic findings in one CASTLE case showed downregulation of thyroid follicular markers and an immune-rich “immune-hot” microenvironment resembling thymic carcinoma.\"}]","The Molecular Landscape of CASTLE: A Rare Thymus-like Head and Neck Cancer | PDF",1790094648,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1bbc687a807c56c2766649178477774.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb4fe60ab417e14426d456e5c55e709d.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ce4f4411c508875974b4800c76959e6.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5477d8b6624edd87caa221c38021faa.webp",980,1385]